Korean J Gastroenterol.  2020 Jun;75(6):311-313. 10.4166/kjg.2020.75.6.311.

Efficacy of Proton Pump Inhibitor in Patients with Non-cardiac Chest Pain

• Kang SH

• KMID: 2504372
• DOI: http://doi.org/10.4166/kjg.2020.75.6.311

Reference

1. Fass R, Achem SR. 2011; Noncardiac chest pain: epidemiology, natural course and pathogenesis. J Neurogastroenterol Motil. 17:110–123. DOI: 10.5056/jnm.2011.17.2.110. PMID: 21602987. PMCID: PMC3093002.

2. Achem SR, DeVault KR. 2000; Recent developments in chest pain of undetermined origin. Curr Gastroenterol Rep. 2:201–209. DOI: 10.1007/s11894-000-0062-4. PMID: 10957931.

3. Pandak WM, Arezo S, Everett S, et al. 2002; Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring. J Clin Gastroenterol. 35:307–314. DOI: 10.1097/00004836-200210000-00006. PMID: 12352293.

4. Faybush EM, Fass R. 2004; Gastroesophageal reflux disease in noncardiac chest pain. Gastroenterol Clin North Am. 33:41–54. DOI: 10.1016/S0889-8553(03)00131-6.

5. Nilsson S, Scheike M, Engblom D, et al. 2003; Chest pain and ischaemic heart disease in primary care. Br J Gen Pract. 53:378–382. PMID: 12830565. PMCID: PMC1314597.

6. Verdon F, Burnand B, Herzig L, Junod M, Pécoud A, Favrat B. 2007; Chest wall syndrome among primary care patients: a cohort study. BMC Fam Pract. 8:51. DOI: 10.1186/1471-2296-8-51. PMID: 17850647. PMCID: PMC2072948.

7. Klinkman MS, Stevens D, Gorenflo DW. 1994; Episodes of care for chest pain: a preliminary report from MIRNET. Michigan Research Network. J Fam Pract. 38:345–352. PMID: 8163958.

8. Savarino E, Tutuian R, Zentilin P, et al. 2010; Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol. 105:1053–1061. DOI: 10.1038/ajg.2009.670. PMID: 19997095.

9. Nasr I, Attaluri A, Coss-Adame E, Rao SS. 2012; Diagnostic utility of the oesophageal balloon distension test in the evaluation of oesophageal chest pain. Aliment Pharmacol Ther. 35:1474–1481. DOI: 10.1111/j.1365-2036.2012.05103.x. PMID: 22524415. PMCID: PMC4470272.

10. DeMeester TR, O'Sullivan GC, Bermudez G, Midell AI, Cimochowski GE, O'Drobinak J. 1982; Esophageal function in patients with angina-type chest pain and normal coronary angiograms. Ann Surg. 196:488–498. DOI: 10.1097/00000658-198210000-00013. PMID: 7125735. PMCID: PMC1352717.

11. Fass R, Fennerty MB, Ofman JJ, et al. 1998; The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology. 115:42–49. DOI: 10.1016/S0016-5085(98)70363-4. PMID: 9649457.

12. Dickman R, Emmons S, Cui H, et al. 2005; The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther. 22:547–555. DOI: 10.1111/j.1365-2036.2005.02620.x. PMID: 16167971.

13. Kim JH, Sinn DH, Son HJ, Kim JJ, Rhee JC, Rhee PL. 2009; Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients. J Gastroenterol Hepatol. 24:1504–1509. DOI: 10.1111/j.1440-1746.2009.05859.x. PMID: 19467139.

14. Hong SJ. 2010; Diagnosis and management of esophageal chest pain. Korean J Gastroenterol. 55:217–224. DOI: 10.4166/kjg.2010.55.4.217. PMID: 20389174.

15. Min YW, Rhee PL. 2015; Noncardiac chest pain: update on the diagnosis and management. Korean J Gastroenterol. 65:76–84. DOI: 10.4166/kjg.2015.65.2.76. PMID: 25716709.

16. Xia HH, Lai KC, Lam SK, et al. 2003; Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain. Aliment Pharmacol Ther. 17:369–377. DOI: 10.1046/j.1365-2036.2003.01436.x. PMID: 12562449.

17. Bautista J, Fullerton H, Briseno M, Cui H, Fass R. 2004; The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther. 19:1123–1130. DOI: 10.1111/j.1365-2036.2004.01941.x. PMID: 15142202.

18. Kim JH, Rhee PL. 2012; Recent advances in noncardiac chest pain in Korea. Gut Liver. 6:1–9. DOI: 10.5009/gnl.2012.6.1.1. PMID: 22375165. PMCID: PMC3286725.

19. Choi JK, Shim HI, Shin CM, et al. 2020; Therapeutic response to 20 mg of esomeprazole twice daily in patients with gastroesophageal reflux disease-related non-cardiac chest pain: an open-label randomized pilot study. Korean J Gastroenterol. 75:333–340. DOI: 10.4166/kjg.2020.75.6.333. PMID: 32581204.

20. Vachhani R, Olds G, Velanovich V. 2009; Esomeprazole: a proton pump inhibitor. Expert Rev Gastroenterol Hepatol. 3:15–27. DOI: 10.1586/17474124.3.1.15. PMID: 19210109.

21. Kinoshita Y, Kato M, Fujishiro M, et al. 2018; Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study. J Gastroenterol. 53:834–844. DOI: 10.1007/s00535-017-1417-z. PMID: 29188387. PMCID: PMC6006226.